Therapeutic vaccine against Streptococcus sobrinus-induced caries

Journal of Dental Research

Volumn 83, Issue 4, 2004, Pages 354-358

  Dinis, M ^a   Tavares, D ^a,b   Fonseca, A J M M ^c   Faria, R ^a   Ribeiro, A ^a,b   Silverio Cabrita A M ^c   Ferreira, P ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Dental caries; Streptococcus sobrinus; Vaccination; VIP

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; IMMUNOGLOBULIN A; VIRULENCE FACTOR;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DENTAL CARIES; DISEASE MODEL; FEMALE; IMMUNIZATION; IMMUNOLOGY; MALE; RAT; SALIVA; STREPTOCOCCUS SOBRINUS; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; DENTAL CARIES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN A; MALE; RATS; RATS, WISTAR; SALIVA; STREPTOCOCCUS SOBRINUS; VIRULENCE FACTORS;

EID: 2342464955     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910408300416     Document Type: Article

References (33)

1. Arala-Chaves MP (1992). Is prophylactic immunostimulation of the host against pathogenic microbial antigens an adequate strategy of immunoprotection? Scand J Immunol 35:495-500.
2. Arala-Chaves MP, Higerd TB, Porto MT, Munoz J, Goust JM, Fudenberg HH, et al. (1979). Evidence for the synthesis and release of strongly immunosuppressive noncytotoxic substances by Streptococcus intermedius. J Clin Invest 64:871-883.
3. Arala-Chaves MP, Ribeiro Ajos S, Vilanova M, Porto MT, Santarém MG, Lima M (1988). Correlation between B-cell mitogenicity and immunosuppressor effects of a protein released by porcine monocyte infected with African swine fever virus. Am J Vet Res 49:1955-1961.
4. Blander SJ, Horwitz MA (1991). Vaccination with the major secretory protein of Legionella induces humoral and cell-mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella. J Immunol 147:285-291.
5. Caufield PW (1997). Dental caries - a transmissible and infectious disease revisited: a position paper. Pediatr Dent 19:491-498.
6. Coykendall AL, Gustafson KB (1986). Taxonomy of Streptococcus mutans. In: Molecular microbiology and immunology of Streptococcus mutans. Hamada S, Michalek SM, Kiyono K, Menaker K, McGhee JR, editors. Amsterdam: Elsevier, pp. 21-28.
7. de Soet JJ, van Loveren C, Lammens AJ, Pavicic MJ, Homburg CH, ten Cate JM, et al. (1991). Differences in cariogenicity between fresh isolates of Streptococcus sobrinus and Streptococcus mutans. Caries Res 25:116-122.
8. Ferreira P, Soares R, Ribeiro A, Arala-Chaves M (1988). Correlation between specific immunosuppression and polyclonal B cell activation induced by a protein secreted by Streptococcus mutans. Scand J Immunol 27:549-554.
9. Ferreira P, Brás A, Tavares D, Vilanova M, Ribeiro A, Videira A, et al. (1997). Purification, and biochemical and biologic characterization of an immunosuppressive and lymphocyte mitogenic protein secreted by Streptococcus sobrinus. Int Immunol. 9:1735-1743.
10. Hajishengallis G, Michalek SM (1999). Current status of a mucosal vaccine against dental caries. Oral Microbiol Immunol 14:1-20.
11. Hanada N (2000). Current understanding of the cause of dental caries. Jpn J Infect Dis 53:1-5.
12. Horwitz MA, Lee BW, Dillon BJ, Harth G (1995). Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 92:1530-1534.
13. Keyes PH (1958). Dental caries in the molar teeth of rats. II. A method for diagnosing and scoring several types of lesions simultaneously. J Dent Res 37:1088-1099.
14. Lima M, Bandeira A, Portnoi D, Ribeiro A, Chaves MA (1992). Protective effect of a T-cell-dependent, immunosuppressive, B-cell-mitogenic protein (F3′ EP-Si or P90) produced by Streptococcus intermedius. Infect Immun 60:3571-3578.
15. Loesche WJ (1986). Role of Streptococcus mutans in human dental decay. Microbiol Rev 50:353-380.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:193-265.
17. Michalek SM, Eldridge JH, Curtis R III, Rosenthal KL (1994). Antigen delivery systems: new approaches to mucosal immunization. In: Handbook of mucosal immunology. Ogra PL, Mestecky J, Lamn ME, Strober W, McGhee J, Bienenstock J, editors. San Diego, CA: Academic Press Inc., pp. 373-390.
18. Minoprio P, Coutinho A, Spinella S, Hontebeyrie-Joskowicz M (1991). Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease. Int Immunol 3:427-433.
19. Newbrun E (1983). Cariology. 2nd ed. Baltimore: Williams and Wilkins.
20. O'Hagan DT, MacKichan ML, Singh M (2001). Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng 18:69-85.
21. Reina-San-Martin B, Degrave W, Rougeot C, Cosson A, Chamond N, Cordeiro-Da-Silva A, et al. (2000). A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med 6:890-897.
22. Santarém MM, Porto MT, Ferreira P, Soares R, Arala-Chaves M (1987). Semi-purification of an immunosuppresssor substance secreted by Streptococcus mutans that plays a role in the protection of the bacteria in the host. Scand J Immunol 26:755-761.
23. Smith DJ, Heschel R, King WF, Taubman AM (1999). Antibody to glucosyltransferase induced by synthetic peptides associated with catalytic regions of alpha-amylases. Infect Immun 67:2638-2642.
24. Soares R, Ferreira P, Santarém MM, Teixeira da Silva M, Arala-Chaves M (1990). Low T- and B-cell reactivity is an apparently paradoxical request for murine immunoprotection against Streptococcus mutans. Murine protection can be achieved by immunization against B-cell mitogen produced by these bacteria. Scand J Immunol 31:361-366.
25. Strindelius L, Degling Wikingsson L, Sjoholm I (2002). Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination. Infect Immun 70:1434-1442.
26. Taubman MA, Smith DJ, Holmberg CJ, Eastcott JW (2000). Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries. Infect Immun 68:2698-2703.
27. Tavares D, Salvador A, Ferreira P, Arala-Chaves M (1993). Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host. Infect Immun 61:1881-1888.
28. Tavares D, Ferreira P, Vilanova M, Videira A, Arala-Chaves M (1995). Immunoprotection against systemic candidiasis in mice. Int Immunol 7:785-796.
29. Tavares D, Ferreira P, Arala-Chaves M (2000). Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J Infect Dis 182:266-273.
30. Vilanova M, Ferreira P, Ribeiro A, Arala-Chaves M (1999). The biological effects induced in mice by p36, a proteinaceous factor of virulence produced by African swine fever virus, are mediated by interleukin-4 and also to a lesser extent by interleukin-10. Immunology 96:389-395.
31. Walden DC, Wilensky GR (1982). National health care expenditure study. Dental services: use, expenditures and source of payment. Data Review 8. USDHHS Publ. No. 88. Washington, DC: Department of Health and Human Services.
32. Wu HY, Nahm MH, Guo Y, Russell MW, Briles DE (1997a). Intranasal immunization of mice with PspA (pneumococal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis 175:839-846.
33. Wu HY, Nguyen H, Russell MW (1997b). Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol 46:506-513.